Use of atorvastatin as an anti-inflammatory treatment in Crohn's disease.
about
Current and Emerging Uses of Statins in Clinical Therapeutics: A ReviewAtorvastatin reduces plasma levels of chemokine (CXCL10) in patients with Crohn's disease.Medical therapy of stricturing Crohn's disease: what the gut can learn from other organs - a systematic review.Current and emerging drugs for the treatment of inflammatory bowel disease.Comorbidity in inflammatory bowel disease.Statins are associated with reduced use of steroids in inflammatory bowel disease: a retrospective cohort study.Comparative protective effect of hawthorn berry hydroalcoholic extract, atorvastatin, and mesalamine on experimentally induced colitis in ratsCrohn's disease: evidence for involvement of unregulated transcytosis in disease etio-pathogenesisRational for statin use in psoriatic patients.Potential Immunomodulatory Effects of Statins in Inflammatory Bowel Disease.Atorvastatin promotes the expansion of myeloid-derived suppressor cells and attenuates murine colitis.An overview of lipid abnormalities in patients with inflammatory bowel diseaseRandomized clinical trial: atorvastatin versus placebo in patients with acute exacerbation of mild to moderate ulcerative colitis.Statins inhibit chemotactic interaction between CCL20 and CCR6 in vitro: possible relevance to psoriasis treatment.Atorvastatin exerts anti-nociceptive activity and decreases serum levels of high-sensitivity C-reactive protein and tumor necrosis factor-α in a rat endometriosis model.Reply: To PMID 25344905.Differentially expressed genes in human peripheral blood as potential markers for statin response
P2860
Q28076346-1E5ED5C1-0DA5-4967-9584-FFBF23DCA6CEQ33440583-FC11955A-BDB8-4AC1-9664-C64DAEB797E9Q34504710-E91D64AF-FD02-435E-AC53-8474D987C893Q34883210-D86EBCC2-9786-4639-A495-2F85A5840D09Q35065318-A0AE25F7-1873-40AD-BA14-97360DC925B8Q35541718-6EB7E3AF-C8E1-4F5D-9F6D-8D6EA3F19C02Q37035787-2DC37EE5-F865-4F40-98C9-67952B03865EQ37862587-F71B5A8C-BDA3-40EF-9C58-85F00E996B9BQ38113531-621E03F7-FF06-44F9-87DB-4D5AA81E2430Q38711126-2A261B5B-D4E4-416D-B94D-18B017A112CDQ39169148-BCE800C6-E303-4C86-9206-3695F08AEC57Q42406811-AC43E227-32A6-460B-8F2B-0E6ACE0A2E98Q45852639-37E8D1AD-9B5B-4C0C-8DAF-1C5991EA5599Q50997081-1D76BAA5-AE65-4432-80E4-676654C5C80DQ51135178-9EB9D02E-844B-47B3-A644-0AC0BC05D6FBQ53651385-530C32CB-4C09-48E1-A7F8-8876FB278BBFQ57910694-4F80EB18-25BD-4AF5-8593-11D283CB083A
P2860
Use of atorvastatin as an anti-inflammatory treatment in Crohn's disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Use of atorvastatin as an anti-inflammatory treatment in Crohn's disease.
@en
Use of atorvastatin as an anti-inflammatory treatment in Crohn's disease.
@nl
type
label
Use of atorvastatin as an anti-inflammatory treatment in Crohn's disease.
@en
Use of atorvastatin as an anti-inflammatory treatment in Crohn's disease.
@nl
prefLabel
Use of atorvastatin as an anti-inflammatory treatment in Crohn's disease.
@en
Use of atorvastatin as an anti-inflammatory treatment in Crohn's disease.
@nl
P2093
P2860
P356
P1476
Use of atorvastatin as an anti-inflammatory treatment in Crohn's disease.
@en
P2093
A Bredberg
S Janciauskiene
P2860
P304
P356
10.1038/BJP.2008.369
P407
P577
2008-09-22T00:00:00Z